Zusammenfassung
Hintergrund
Das intraoperative Floppy-Iris-Syndrom (IFIS) ist eine häufige Komplikation während einer Kataraktoperation, die oft ein aufwendiges Komplikationsmanagement durch die OperateurIn erfordert und mit schwerwiegenden Folgen für die PatientInnen enden kann. Eine Vielzahl von Medikamenten wurde in den letzten Jahren mit dieser Komplikation in Verbindung gebracht. Ziel dieser Arbeit war es, einen Überblick über diese Komplikation und eine Übersicht über jene Medikamente zu geben, die in der Literatur mit einem IFIS in Verbindung gebracht werden.
Methoden
Es erfolgte eine systematische Literatursuche über das IFIS und Medikamente, die mit diesem in Verbindung gebracht werden. Anschließend wird das Ergebnis mit Erfahrungswerten an unserer Abteilung diskutiert.
Schlussfolgerungen
Mit dem Auftreten eines IFIS muss bei einer Vielzahl von laufenden Medikationen gerechnet werden. Die Anzahl an IFIS Fällen und der Anteil an betroffenen Frauen ist gestiegen. Gründe hierfür dürften eine höhere Sensibilität für diese Komplikation unter den OperateurInnen und eine steigende Verschreibung von Medikamenten mit einem erhöhten Risiko für ein IFIS darstellen.
Summary
Background
The intraoperative floppy iris syndrome (IFIS) is a frequent complication during cataract surgery. An IFIS often requires an extensive management of complications and can end in poor surgery outcome. Multiple drugs have been found to be associated with this complication over the past years. The aim of this paper is to give an overview on the complication and to summarize medications that are known to be associated with an IFIS.
Methods
We performed a systematic review on IFIS and on drugs, which are associated with it. The collected results then were compared to operating experience at our department.
Conclusions
The occurrence of IFIS has to be expected with a variety of concurrent medications. The number of IFIS cases and the percentage of affected females have increased. The observations might be due to a rising awareness of surgeons or to an increasing number of causative medications on the market.
Literatur
Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsolusin. J Cataract Refract Surg. 2005;31(4):664–7.
Chatziralli IP, Sergentanis TN. Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology. 2011;118(4):730–5.
Goseki T, Ishikawa H, Ogasawara S, et al. Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: possible mechanism of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2012;38(9):1643–9.
Haridas A, Syrimi M, Al-Ahmar B, Hingorani M. Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates. Graefes Arch Clin Exp Ophthalmol. 2013;251(6):1541–5.
Chang DF, Campbell JR, Colin J, Schweitzer C, Study Surgeon Group. Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin. Ophthalmology. 2014;121(4):829–34.
ASCRS Cataract Clinical Committee, Chang DF, Braga-Mele R, Mamalis N, et al. Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey. J Cataract Refract Surg. 2008;34(7):1201–9.
Masket S, Belani S. Combined preoperative topical atropine sulfate 1 % and intracameral nonpreserved epinephrine hydrochloride 1:4000 for management of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33(7):580–2.
Chang DF, Osher RH, Wang L, Koch DD. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology. 2007;114(5):957–64.
Gurbaxani A, Packard R. Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye (Lond). 2007;21(3):331–2.
Armarnik S, Mimouni M, Rosen E, Assia EI, Segev F. Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients. Graefes Arch Clin Exp Ophthalmol. 2016;254(1):123–7.
Schlote T, Kellner U. Adverse drug reactions in ophthalmology – update 2015/2016. Klin Monbl Augenheilkd. 2016;233(2):203–16.
Srinivasan S, Radomski S, Chung J, Plazker T, Singer S, Slomovic AR. Intraoperative floppy iris syndrome during cataract surgery in men using alpha-blockers for benign prostatic hypertrophy. J Cataract Refract Surg. 2007;33(10):1826–7.
Chadha V, Borooah S, Tey A, Styles C, Singh J. Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol. 2007;91(1):40–2.
Cheung CM, Awan MA, Peh KK, Sandramouli S. Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist. Am J Ophthalmol. 2007;143(6):150–1.
Blouin MC, Blouin J, Perreault S, Lapointe A, Dragomir A. Intraoperative floppy-iris syndrome associated with alpha-1 adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg. 2007;33(7):1227–34.
Bell CM, Hatch WV, Fischer HD, Cernat G, Paterson JM, Gruneir A, et al. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA. 2009;301(19):1991–6.
Casuccio A, Cillino G, Pavone C, Spitale E, Cillino S. Pharmacologic pupil dilation as a predictive test for the risk of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2011;37(8):1447–54.
Shah N, Tendulkar M, Brown R. Should we anticipate intraoperative floppy iris syndrome (IFIS) even with very short history of tamsulosin? Eye (Lond). 2009;23(3):740.
Dhingra N, Rajkumar KN, Kumar V. Intraoperative floppy iris syndrome with doxazosin. Eye (Lond). 2007;21(5):678–9.
Settas G, Fitt AW. Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy. Eye (Lond). 2006;20(12):1431–2.
Issa SA, Dagres E. Intraoperative floppy-iris syndrome and finasteride intake. J Cataract Refract Surg. 2007;33(12):2142–3.
Ugarte M, Leong T, Rassam S, Kon CH. Intraoperative floppy-iris syndrome, alpha1-adrenergic antagonists, and chronic intake of mianserin: is there an association? J Cataract Refract Surg. 2007;33(1):170.
Pringle E, Packard R. Antipsychotic agent as an etiologic agent of IFIS. J Cataract Refract Surg. 2005;31(12):2240–1.
Unal M, Yücel I, Tenlik A. Intraoperative floppy-iris syndrome associated with chronic use of chlorpromazine. Eye (Lond). 2007;21(9):1241–2.
Nguyen DQ, Sebastian RT, Kyle G. Surgeon’s experiences of the intraoperative floppy iris syndrome in the United Kingdom. Eye (Lond). 2007;21(3):443–4.
Cantrell MA, Bream-Rouwenhorst HR, Steffensmeier A, Hemerson P, Rogers M, Stamper B. Intraoperative floppy iris syndrome associated with alpha 1‑adrenergic receptor antagonists. Ann Pharmacother. 2008;42(4):558–63.
Parssinen O, Leppanen E, Keski-Rahkonen P, Mauriala T, Dugue B, Lehtonen M. Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci. 2006;47(9):3766–71.
Neff KD, Sandoval HP, Fernández de Castro LE, Nowacki AS, Vroman DT, Solomon KD. Factors associated with intraoperative floppy iris syndrome. Ophthalmology. 2009;116(4):658–63.
Bilgin B, Ilhan D, Çetinkaya A, Ünal M. Intraoperative floppy iris syndrome associated with quetiapine. Eye (Lond). 2013;27(5):673.
Wong AC, Mak ST. Finasteride-associated cataract and intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2011;37(7):1351–4.
Calotti F, Steen D. Labetalol causing intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33(1):170–1. doi:10.1016/j.jcrs.2006.07.048.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Wahl und P.V. Vecsei-Marlovits geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Wahl, M., Vecsei-Marlovits, P.V. Intraoperatives Floppy-Iris-Syndrom: ein aktueller Überblick. Spektrum Augenheilkd. 30, 227–231 (2016). https://doi.org/10.1007/s00717-016-0307-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00717-016-0307-8